References
- http://www.fda.gov/forconsumers/byaudience/forwomen/ucm118624.htm
- Bretler DM, Hansen PR, Sørensen R, . Discontinuation of hormone replacement therapy after myocardial infarction and short term risk of adverse cardiovascular events: nationwide cohort study. BMJ 2012;344:e1802
- Bretler DM, Hansen PR, Abildstrom SZ, . Use and discontinuation of hormone replacement therapy in women with myocardial infarction: a nationwide study. Br J Clin Pharmacol 2011;71:105–15
- Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999;340:1801–11
- Newton KM, LaCroix AZ, McKnight B, . Estrogen replacement therapy and prognosis after first myocardial infarction. Am J Epidemiol 1997;145:269–77
- Heckbert SR, Kaplan RC, Weiss NS, . Risk of recurrent coronary events in relation to use and recent initiation of postmenopausal hormone therapy. Arch Intern Med 2001; 161:1709–13
- O’Keefe JH Jr, Kim SC, Hall RR, . Estrogen replacement therapy after coronary angioplasty in women. J Am Coll Cardiol 1997;29:1–5
- Sullivan JM, El-Zeky F, Van der Zwaag R, Ramanathan KB. Effect on survival of estrogen replacement therapy after coronary artery bypass grafting. Am J Cardiol 1997;79:847–50
- Hulley S, Grady D, Bush T, . Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998;280:605 13
- Grady D, Herrington D, Bittner V, . Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 2002;288:49–57
- Grodstein F, Manson JE, Stampfer MJ. Postmenopausal hormone use and secondary prevention of coronary events in the Nurses’ Health Study. a prospective, observational study. Ann Intern Med 2001;135:1–8
- Smith PJ, Ornatsky O, Stewart DJ, . Effects of estrogen replacement on infarct size, cardiac remodeling, and the endothelin system after myocardial infarction in ovariectomized rats. Circulation 2000;102:2983–9
- Wright RS, Anderson JL, Adams CD, . 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American Academy of Family Physicians, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons. J Am Coll Cardiol 2011; 57:e215–367
- Cherry N, Gilmour K, Hannaford P, .; ESPRIT team. Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial. Lancet 2002;360:2001–8